Case Number:

IPR2023-00724

Case Type:

IPR

Status:

Trial Instituted

Petitioner:

Mylan Pharmaceuticals Inc. et al.

Patent Owner:

Tech Center:

1. Filed: March 16, 2023 00:00

   Coverage

   1. October 04, 2023

      Never Mind: Ozempic Patents Not Fully In The Clear At PTAB

      The Patent Trial and Appeal Board on Wednesday granted Mylan's request to review whether a patent covering Novo Nordisk's blockbuster drug Ozempic holds up, just two days after clearing the Danish company from challenges to related patents.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login